Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
23/07/2026
ASX stated that the ASX collateral trading has resumed normal operations.
Latest
4 m ago
The Australia S&P/ASX 200 index rose 0.7% in early trading, reaching 8,888.70 points.
4 m ago
Changan Automobile (000625.SZ) applied to the Shenzhen Stock Exchange for approval to issue A-shares to specific investors, and the application was approved.
6 m ago
The Nikkei 225 index has increased by 1%.
6 m ago
U.S. stock index futures fell in early Asian trading as Alphabet and Tesla's share prices dropped after releasing their earnings reports.
6 m ago
The pharmaceutical company Galectin Therapeutics-B (01672) will report in oral presentation format at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) that the weight loss effect of ASC36_35 FDC is superior to the combination of eloralintide and tirzepatide based on preclinical data.
See all latest